DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
84	サルコイドーシス	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02192489 (ClinicalTrials.gov)	November 1, 2014	15/7/2014	A Phase 2 Study With CC-220 in Skin Sarcoidosis	A Phase 2A, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Sequential, Dose-Ascending Study Of CC-220 In Subjects With Chronic Cutaneous Sarcoidosis	Sarcoidosis	Drug: CC-220 0.3 mg Daily;Drug: CC-220 0.6mg Daily;Drug: Placebo	Celgene	NULL	Withdrawn	18 Years	N/A	All	0	Phase 2	NULL

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT02192489
(ClinicalTrials.gov)

November 1, 2014

15/7/2014

A Phase 2 Study With CC-220 in Skin Sarcoidosis

A Phase 2A, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Sequential, Dose-Ascending Study Of CC-220 In Subjects With Chronic Cutaneous Sarcoidosis

Sarcoidosis

Drug: CC-220 0.3 mg Daily;Drug: CC-220 0.6mg Daily;Drug: Placebo

Celgene

NULL

Withdrawn

18 Years

N/A

All

Phase 2

NULL